-The New Indian Express The state health minister T S Singh Deo said that it is "Not Safe" to use any vaccine, which remains in clinical trial mode. RAIPUR: Congress-ruled Chhattisgarh government has categorically declared that it is not in favour of using indigenous Covid19-Covaxin in the vaccination process in the state unless it has completed the recommended testing process with absolute authentication and success. The state health minister T S Singh Deo...

-IndiaSpend.com Many health issues were neglected as COVID-19 hogged global attention in 2020. Apart from the COVID-19 vaccine, what other health issues should be in focus in 2021? New Delhi: COVID-19 demanded the single-minded focus of India's entire healthcare infrastructure all through 2020. In fact, the pandemic hogged so much attention across all aspects of our lives that most other issues of public health were put on the back-burner. Issues such as tackling...

-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...

-The Indian Express India's economy in 2020: As Annus Horribilis 2020 comes to an end, there are positives in the economy: signs of a GDP rebound, and buoyant equity markets. But demand is weak, receipts are down, and the employment situation is grim. All eyes are on the Budget — and on the vaccines In a little over a month, Finance Minister Nirmala Sitharaman will present what she has heralded as “a...

-Livemint.com India has adopted a cautious approach in granting approval to covid-19 vaccines as fast tracking, safety and efficacy remain primary concern NEW DELHI: Safety and efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country. The government's cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked...